Valentina Galbiati
Emanuela Corsini

Valentina Galbiati


Valentina Galbiati received her doctorate in Pharmacological Sciences from University of the Study of Milan (Italy) in 2015 and was a postdoctoral fellow at University of the Study of Milan (Italy) from 2015-2020. From September 2020 she is a Researcher at Department of Pharmacological and Biomolecular Sciences, University of the Study of Milan (Italy), where she conducts research in field of Immunotoxicology and In Vitro alternative methods.  As such she is tenure of courses in the field of Safety and Toxicology of Nanoparticles at the Faculty of Biotechnology, University of Milan. Along with her academic activity, she has successfully supervised 30 undergraduated students and 1 PhD students to completion. She served on the ITCASS (Immunotoxicology and Chemical Allergy Specialty Section – EUROTOX) Committee as Councilor (2018 – 2019) and subsequently as Chair (2019 – up to now). She served as the Postdoctoral Representative for the ITSS (SOT – March 2021 – up to now). She is a member of the SOT and SITOX.

Research activity. She obtained her Ph.D. Pharmacological Sciences in 2014, defending an experimental thesis titled: “Assessment of the allergenic potential of xenobiotics: in vivo in vitro a back-and-forth approach ”. During the Ph.D. period she was a visiting scientist at the University of Barcelona, Faculty of Pharmacy and at the University of Friburg, Medical Centre – Allergy Research Group. In 2011 she took part of the course: “Chemical exposure experiments EST1000 cultures for Demo Assay” University Medical Centre – VUMC (Netherland). She always worked in the field of Immunotoxicity, and in particular she was involved in the alternative in vitro methods to assess the phenomena of allergic contact dermatitis. She was the Principle Investigator for the Colgate-Palmolive Grant for Alternative Research – SOT 2018 Award and partecipated during her carrier in 14 research projects.

She is author/co-author of 47 publications including peer-reviewed articles.